Kilitch Drugs India has received an approval to disinvest company’s entire stake held in Eye Kare Kilitch, being a non-listed company. The board at its meeting held on 15, 2013 has approved for the same.
This step is taken as the Board of Directors do not envisage any increase in growth on the said investment without any additional infusion of funds, which the board do not find feasible.
Kilitch Drugs (India) is engaged in the manufacture of injectibles such as gentamycin sulphate, dexamethason sodium phosphate, B-complex and others. Nasdaq-listed Akorn Inc is a niche generic pharmaceutical company.
